Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of topiroxostat versus allopurinol in gout with hyperuricemia
ChiCTR2400086523Phase 2Not yet recruiting
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of topiroxostat in gout and hyperuricemia (4 arms), sponsored by The Affiliated Hospital of Qingdao University. Primary endpoint: Proportion achieving serum uric acid target. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
topiroxostat
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on ChiCTR2400086523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086523.